BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 29119638)

  • 1. Biphasic papillary renal cell carcinoma is a rare morphological variant with frequent multifocality: a study of 28 cases.
    Trpkov K; Athanazio D; Magi-Galluzzi C; Yilmaz H; Clouston D; Agaimy A; Williamson SR; Brimo F; Lopez JI; Ulamec M; Rioux-Leclercq N; Kassem M; Gupta N; Hartmann A; Leroy X; Bashir SA; Yilmaz A; Hes O
    Histopathology; 2018 Apr; 72(5):777-785. PubMed ID: 29119638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic papillary (biphasic squamoid alveolar) renal cell carcinoma: a clinicopathologic and molecular study of 17 renal cell carcinomas including 10 papillary adenomas.
    Nova-Camacho LM; Acosta AM; Akgul M; Panizo A; Galea LA; Val-Carreres A; Talavera JA; Guerrero-Setas D; Martin-Arruti M; Ruiz I; García-Martos M; Sangoi AR
    Virchows Arch; 2024 Mar; 484(3):441-449. PubMed ID: 38388964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear Cell Renal Cell Carcinoma With Syncytial-Type Multinucleated Giant Tumor Cells: A Clinicopathologic Study of 14 Cases.
    Nova-Camacho LM; Sangoi AR
    Int J Surg Pathol; 2024 Jun; 32(4):731-737. PubMed ID: 37525565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Utility of EMA, Vimentin and CD117 Immunohistochemical Markers in Subtyping Renal Cell Carcinoma in a Nigerian Tertiary Hospital: A 10-year Retrospective Study.
    Nwadiokwu JI; Adegoke OO; Ajani MA; Okolo CA; Awosusi BL; Okebalama VC
    West Afr J Med; 2023 Oct; 40(10):1035-1040. PubMed ID: 37906498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive renal cell carcinoma with biphasic papillary and solid clear cell features harboring IDH2 (R172M) mutation.
    Zhao M; Xia Y; Wang W
    Pathol Res Pract; 2024 Jan; 253():155090. PubMed ID: 38181579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell renal cell carcinoma cells show diffuse expression of phagocytotic markers through the identification of lysosome-rich eosinophilic granules.
    Mahalingam VD; Chaib OS; Kanaan HD; Hafron JM; Zhang PL
    Int Urol Nephrol; 2024 Feb; 56(2):467-473. PubMed ID: 37777637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications.
    Argani P; Medeiros LJ; Matoso A; Baraban E; Lotan T; Pawel BR; McKenney JK; Mehra R; Falzarano SM; Pallavajjalla A; Lin MT; Patel S; Rawwas J; Bendel AE; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2023 Dec; 47(12):1335-1348. PubMed ID: 37522346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary renal neoplasm with reverse polarity: a clinicopathologic study of 43 cases with a focus on the expression of KRAS signaling pathway downstream effectors.
    Kim B; Lee S; Moon KC
    Hum Pathol; 2023 Dec; 142():1-6. PubMed ID: 37797754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiologic and clinicopathologic features of eosinophilic solid and cystic renal cell carcinoma: report of two cases and review of literature.
    Yin J; Zenezan D; Doan KD; Nobee A; Wei S; Mollaee M; Proca DM
    Int J Clin Exp Pathol; 2023; 16(10):303-308. PubMed ID: 37970333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rare Case of Clear Cell Carcinoma, Müllerian Type in the Renal Pelvis of a 21-Year-Old Woman.
    Perez D; Naous R
    Case Rep Pathol; 2018; 2018():1521598. PubMed ID: 29805829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic clear cell papillary renal cell 'tumour'.
    Gupta S; Dasari S; Sharma V; Atwell TD; Sivasankaran G; Smoley SA; Hardcastle JJ; Lohse CM; Tekin B; Jimenez RE; Thompson RH; Boorjian SA; Leibovich BC; Cheville JC
    Histopathology; 2024 Apr; 84(5):905-909. PubMed ID: 38148678
    [No Abstract]   [Full Text] [Related]  

  • 12. Synchronous Clear Cell and Papillary Renal Cell Carcinoma: Dual Tumour of Same Kidney.
    Narang V; Jindal S; Soni A; Kaur H; Ahluwalia A; Kakkar C; Chahal HS
    Indian J Surg Oncol; 2022 Dec; 13(4):780-782. PubMed ID: 36687224
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex.
    Williamson SR; Hornick JL; Eble JN; Gupta NS; Rogers CG; True L; Grignon DJ; Cheng L
    Hum Pathol; 2018 May; 75():10-15. PubMed ID: 29180251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and emerging renal entities: a perspective post-WHO 2016 classification.
    Trpkov K; Hes O
    Histopathology; 2019 Jan; 74(1):31-59. PubMed ID: 30565301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features.
    Denize T; Just PA; Sibony M; Blons H; Timsit MO; Drossart T; Jakubowicz D; Broudin C; Morini A; Molina T; Vano Y; Auvray-Kuentz M; Richard S; Mejean A; Gimenez Roqueplo AP; Burnichon N; Verkarre V
    Mod Pathol; 2021 Mar; 34(3):647-659. PubMed ID: 32770124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD57 in biphasic squamoid alveolar renal cell carcinoma.
    Suárez-Vilela D; Izquierdo FM
    Pathol Int; 2020 Jan; 70(1):56-57. PubMed ID: 31782215
    [No Abstract]   [Full Text] [Related]  

  • 17. Biphasic squamoid alveolar renal carcinoma with positive CD57 expression: A clinicopathologic study of three cases.
    Zhou L; Xu H; Zhou Y; Zhou J; Zhang P; Yang X; Wang C
    Pathol Int; 2019 Sep; 69(9):519-525. PubMed ID: 31369187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Squamoid Cells in Biphasic Squamoid Alveolar Renal Carcinoma Present Cytophagocytosis (Not Emperipolesis) of Apoptotic Neutrophilic Granulocytes.
    Suárez-Vilela D; Izquierdo FM; Méndez-Álvarez JR; Velasco-Alonso J
    Am J Surg Pathol; 2018 Mar; 42(3):420-422. PubMed ID: 29194094
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinicopathological and molecular characterisation of papillary renal neoplasm with reverse polarity and its renal papillary adenoma analogue.
    Chang HY; Hang JF; Wu CY; Lin TP; Chung HJ; Chang YH; Pan CC
    Histopathology; 2021 Jun; 78(7):1019-1031. PubMed ID: 33351968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.
    Kim SS; Cho YM; Kim GH; Kee KH; Kim HS; Kim KM; Kim JH; Choi C
    Mod Pathol; 2020 Apr; 33(4):690-699. PubMed ID: 31953522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.